Vical Overview
- Founded
-
1987

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Vical General Information
Description
Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics for the treatment of skin diseases. Its pipeline consists of therapeutics for Hyperhidrosis, Cutaneous T-cell lymphoma, Psoriasis, and Other prevalent severe skin diseases. The company's pipeline products include Sofpironium Bromide, BBI-3000 and BBI-6000 among others.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Drug Delivery
Acquirer
Primary Office
- 10390 Pacific Center Court
- San Diego, CA 92121
- United States
Vical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
12. Merger/Acquisition | 03-Sep-2019 | 00000 | Completed | Generating Revenue | ||
11. Secondary Transaction - Open Market | 00000 | Completed | Generating Revenue | |||
10. 2PO | 05-Jan-2012 | 0000 | 00000 | Completed | Generating Revenue | |
9. PIPE | 08-Jan-2010 | 0000 | 00000 | Completed | Generating Revenue | |
8. PIPE | 30-Jul-2009 | 0000 | 000.00 | Completed | Generating Revenue | |
7. PIPE | 26-May-2009 | 0000 | 000.00 | Completed | Generating Revenue | |
6. PIPE | 22-May-2009 | 000.00 | 000.00 | Completed | Generating Revenue | |
5. PIPE | 23-Jun-2008 | 000.00 | 000.00 | Completed | Generating Revenue | |
4. PIPE | 01-Oct-2006 | $12.5M | $26.5M | Completed | Generating Revenue | |
3. 2PO | 23-Jul-1993 | $14M | $14M | Completed | Generating Revenue |
Vical Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics f
Biotechnology
San Diego, CA
00000
000000&0
00000
Vical Competitors (26)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | 000 | 000.00 | 00000000 | 000.00 |
0000000 | Formerly VC-backed | San Diego, CA | 00 | 00000 | 000000000 | 00000 |
000000 00000000000 | Formerly VC-backed | Boston, MA | 0000 | 00.000 | 000000&0 | |
000000 | Corporation | Durham, NC | 00 | 000.00 | 000000000 | 000.00 |
000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
Vical Patents
Vical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20130273078-A1 | Synergistic anti-tumor efficacy using alloantigen combination immunotherapy | Abandoned | 20-Sep-2011 | 00000000000 | |
AU-2013201121-A1 | Synergistic anti-tumor efficacy using alloantigen combination immunotherapy | Abandoned | 20-Sep-2011 | 00000000000 | |
US-20130071403-A1 | Synergistic anti-tumor efficacy using alloantigen combination immunotherapy | Abandoned | 20-Sep-2011 | 00000000000 | |
US-20130280265-A1 | Synergistic anti-tumor efficacy using alloantigen combination immunotherapy | Abandoned | 20-Sep-2011 | 00000000000 | |
GB-2461832-A | Methods of treating measles infectious disease in mammals | Withdrawn | 29-May-2007 | C07K14/005 | 0 |
Vical Executive Team (9)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Adam Levy | Executive |
Vical Former Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Azimuth Opportunity | Investment Bank | Minority | 000 0000 | 000000 0 | |
Federated Kaufmann Fund | Mutual Fund | Minority | 000 0000 | 000000 0 | |
Mentor Capital | Mezzanine | Minority | 000 0000 | 000000 0 | |
Morgenthaler Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
National Institutes of Health | Government | 000 0000 | 000000 0 |
Vical Investments & Acquisitions (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
00000000 0000 | 03-Sep-2019 | 0000000 00 | Drug Delivery | ||
00000 00 | 01-Jun-2006 | 0000 | 000.00 | Biotechnology | |
Inovio Pharmaceuticals | 03-Jan-2006 | PIPE | 000.00 | Biotechnology |
Vical Exits (3)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
00000000 0000000 | 03-Sep-2019 | 0000000 000000 | Completed |
|
|
00000 00 | 01-Jun-2006 | 0000 | 000.00 | Completed |
|
Inovio Pharmaceuticals | 03-Jan-2006 | PIPE | 000.00 | Completed |
|